Return to homepagePandemic Pact

To pursue targeted delivery of Covid-19 coronavirus antigens to antigen presenting cells in the form of nanobody-antigen adducts in the presence of approved adjuvants to elicit protective B- and T-cell (inluding CD8) responses as a possible vaccine strategy.

  • Funded by Emergent Ventures Fast Grants
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    Emergent Ventures Fast Grants

  • Principal Investigator

    Dr. Hidde Ploegh

  • Research Location

    United States of America

  • Lead Research Institution

    Harvard University

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract